Mackay Shields LLC Viatris Inc Transaction History

Mackay Shields LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$9.95 - $12.27 $1.73 Million - $2.13 Million	-173,561 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $70,779 - $111,111	-7,215 Reduced 3.99%	173,561 $1.89 Million
Q4 2021 Feb 04, 2022	SELL	$12.09 - $14.68 $52,035 - $63,182	-4,304 Reduced 2.33%	180,776 $2.45 Million
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $70,887 - $80,945	-5,350 Reduced 2.81%	185,080 $2.51 Million
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $201,242 - $250,583	-15,516 Reduced 7.53%	190,430 $2.72 Million
Q1 2021 May 14, 2021	BUY	$13.59 - $18.54 $52,090 - $71,063	3,833 Added 1.9%	205,946 $2.88 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $2.89 Million - $3.79 Million	202,113 New	202,113 $3.79 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.